Related Experiment Videos
Which Bisphosphonate? It's the Compliance!: Decision Analysis.
You Jin Lee1, Chan Ho Park2, Young-Kyun Lee2
1Department of Internal Medicine, Center for Thyroid Cancer, National Cancer Center, Goyang, Korea.
Journal of Bone Metabolism
|June 14, 2016
Summary
Patient adherence to bisphosphonates is key for preventing osteoporotic fractures in postmenopausal women, significantly impacting quality of life more than the specific drug choice.
Area of Science:
- Pharmacoeconomics
- Geriatric Medicine
- Bone Health
Background:
- Osteoporotic fractures pose a significant health risk to postmenopausal women.
- The optimal bisphosphonate regimen for fracture prevention remains debated.
- Quality of life is a critical factor in treatment efficacy.
Purpose of the Study:
- To compare the efficacy of different bisphosphonates for preventing osteoporotic fractures.
- To evaluate bisphosphonate effectiveness based on health-related quality of life.
- To utilize decision analysis for optimizing treatment selection.
Main Methods:
- A decision analysis model was developed incorporating fracture probabilities and quality of life utilities.
- Probabilities were derived from a comprehensive literature review.
- Health-related quality of life was established by expert consensus.
- A roll back tool and sensitivity analysis were employed to determine the most effective bisphosphonate.
Main Results:
- The decision model indicated that bisphosphonates with higher patient compliance yielded better quality of life outcomes.
- Sensitivity analysis revealed ibandronate as potentially more beneficial if compliance exceeded 0.589.
- Patient adherence emerged as a dominant factor in treatment success.
Conclusions:
- Patient compliance is the most critical factor for improving quality of life in real-world bisphosphonate use for fracture prevention.
- The choice of bisphosphonate is secondary to ensuring patient adherence.
- Decision analysis models can effectively guide treatment choices by prioritizing patient adherence.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
61
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
61
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Dosage Regimens: Partial Pharmacokinetic Parameters
246
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
246
Peritoneal Dialysis III: Nursing Management
1.3K
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.3K
Bioequivalence studies: Biowaivers
376
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
376
Dosage Regimen Designs: Nomograms and Tabulations
285
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
285